ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994